Stock Taper Revenue: Increased 4% sequentially to $10.0 million, but decreased 6% year-over-year.
Net Income: $3.31 million ($0.68 per diluted share), down from $4.03 million ($0.83 per share) in the prior year, primarily due to decreased revenue and lower margins.
Gross Margin: Decreased to 78% from 86% year-over-year, attributed to a less profitable product mix and strong distributor sales.
Operating Margin: 58%, Pretax Margin: 65%, Net Margin: 52%.
Expenses: Total expenses decreased 7% year-over-year, with a 3% increase in R&D expenses and a 23% decrease in SG&A.
Tax Rate: Increased to 20% from 17% year-over-year, but expected to normalize between 16% and 17% for the full fiscal year.
Product Sales: Nondefense sales increased by 21%, while defense sales decreased by 64%, representing 8% of total revenue.
R&D Focus: Continued investment in new product development, with three new products launched in the past quarter, including a rotation sensor and a wafer-level chip scale voltage regulator.
New Equipment: Installation of new production equipment aimed at enhancing capabilities and increasing production efficiency, particularly for wafer-level chip scale packaging.
Market Focus: Emphasis on high-value markets such as medical devices, electric vehicles, and robotics, with participation in trade shows to generate leads.
Growth Expectations: Management expressed optimism about sequential growth in the current quarter, driven by strong nondefense sales and new product introductions.
R&D and Product Development: The new equipment is expected to accelerate product development and contribute to future revenue growth, particularly in industrial markets.
Tax Benefits: Anticipated tax credits from advanced manufacturing investments are expected to provide cash flow relief.
Defense Sales Volatility: A significant decline in defense-related sales, which are subject to procurement cycles, poses a risk to overall revenue stability.
Gross Margin Pressure: The decrease in gross margin indicates challenges in maintaining profitability amid a changing product mix.
Contract R&D Revenue: A 68% decrease in contract R&D revenue raises concerns about future revenue streams from this segment, which is primarily defense-related.
Economic Environment: Potential headwinds from economic uncertainties, tariffs, and trade barriers could impact future sales and profitability.
Future Growth from New Equipment: Management confirmed that the new equipment is expected to enhance both capabilities and revenue growth, particularly in industrial markets.
Domestic Supply Chain: The introduction of wafer-level chip scale packaging is expected to bolster domestic supply chain capabilities, reducing reliance on overseas suppliers.
Market Opportunities: There is a focus on high-value markets such as robotics and medical devices, with management expressing confidence in capturing design wins in these areas.
Defense Market Strategy: While defense contracts are pursued, management clarified that they do not see defense as a primary growth driver, focusing instead on broader market opportunities.
Interest Income: An increase in interest income was noted, attributed to new securities purchased at higher interest rates, despite a decrease in cash and cash equivalents. Overall, NVE Corporation reported mixed financial results with a positive outlook on growth driven by new products and strategic investments, while facing challenges in defense sales and margin pressures.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT